CA
NZ
UK
AU
IND
US
Qualys, Inc. Chief Financial Officer Joo Mi Kim reported the acquisition of 26,179 restricted stock units on November 5, 2026, in a statement of changes in beneficial ownership filed with the SEC on November 6, 2026.
Qualys, Inc. Chief Legal Officer Bruce K. Posey reported the acquisition of 15,241 restricted stock units on November 5, 2026, in a statement of changes in beneficial ownership filed with the SEC on November 6, 2026.
Mondelez International, Inc. Chief Executive Officer and Director Dirk Van de Put filed a Form 4 on November 6, 2026, disclosing the exercise of stock options and same-day sales of Class A Common Stock on November 4 and 5, 2026, pursuant to a Rule …
Jack Sinclair, Chief Executive Officer and Director of Sprouts Farmers Market, Inc., filed a Form 4 on November 6, 2026, disclosing the exercise of stock options and sale of common stock on November 4 and November 5, 2026, pursuant to a Rule 10b5-1 trading …
Joshua M. Eizen, Chief Operating Officer and Chief Legal Officer of AN2 Therapeutics, Inc., filed a Form 4 on November 6, 2026, disclosing a sale of common stock on November 5, 2026, to cover tax withholding obligations from vesting RSUs.
Jaime Eduardo Gualy, Chief Operating Officer of T1 Energy Inc., filed a Form 4 on November 6, 2026, disclosing the vesting and settlement of 33,333 Restricted Stock Units and the withholding of 8,117 shares for tax obligations, both occurring on November 4, 2026.
Sumedh S. Thakar, CEO and President of Qualys, Inc., filed a Form 4 on November 6, 2026, disclosing the acquisition of 48,028 restricted stock units in Qualys common stock on November 5, 2026, at a price of $0.
Director George R. Krouse Jr. filed a Form 4 with the SEC on November 6, 2026, disclosing a gift of 300 shares of SBA Communications Corp Class A Common Stock on November 4, 2026.
Thomas Mahrer, Chief Accounting Officer of T1 Energy Inc., filed a Form 4 on November 6, 2026, disclosing the vesting and settlement of 25,000 Restricted Stock Units on November 4, 2026, along with the withholding of 6,088 shares to satisfy tax obligations.
Director Keith Murphy filed a Form 4 with the SEC on November 6, 2026, disclosing the grant of a stock option to purchase 5,000 shares of Matinas BioPharma Holdings, Inc. common stock under the company's 2025 Equity Incentive Plan.
Please wait processing your request...